Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.83 USD
Change Today +0.21 / 3.17%
Volume 753.5K
TXMD On Other Exchanges
As of 8:04 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/22/15 - $7.49
52 Week Low
05/7/14 - $3.42
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal discomfort. In addition, it manufactures and distributes branded and generic prescription prenatal, as well as OTC vitamins. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

100 Employees
Last Reported Date: 03/12/15
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $550.0K
President, Secretary and Director
Total Annual Compensation: $350.0K
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $345.0K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $213.2K
Vice President of Finance
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2014.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Proposes an Amendment to Amended and Restated Articles of Incorporation

TherapeuticsMD, Inc. announced that at its AGM to be held on June 11, 2015, proposed an amendment to amended and restated articles of incorporation to increase the number of authorized shares of common stock from 250,000,000 shares to 350,000,000 shares.

TherapeuticsMD, Inc. Replaces Rosenberg, Rich, Baker, Berman & Company with Grant Thornton LLP as Independent Registered Public Accounting Firm

On March 25, 2015, the Audit Committee of the Board of Directors of TherapeuticsMD, Inc. voted to dismiss Rosenberg Rich Baker Berman & Company as the company's independent registered public accounting firm, and to engage Grant Thornton LLP as the company's independent registered public accounting firm for the 2015 fiscal year. The Company notified RRBB of its dismissal on March 26, 2015 and engaged GT effective March 30, 2015.

TherapeuticsMD, Inc. Announces Executive Changes

TherapeuticsMD, Inc. announced that on March 18, 2015, the board of directors appointed Mr. Angus C. Russell and Mr. J. Martin Carroll to serve as directors. Mr. Russell previously served as chief executive officer of Shire PLC. Mr. Carroll previously served as president and chief executive officer of Boehringer Ingelheim Corp. from 2003 until 2011 and as global head of strategy and development for Boehringer Ingelheim (Germany) from 2009 through 2012. The Board has determined that each of Mr. Russell and Mr. Carroll is independent under the rules of the NYSE MKT. As directors of the company, each of Mr. Russell or Mr. Carroll will receive compensation in the same manner as the company's other directors, which compensation the company previously disclosed in its definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 17, 2014. Also on March 18, 2015, Mr. Randall Stanicky resigned from his position as a director. To the knowledge of the company, Mr. Stanicky did not resign as the result of any disagreement between himself and the company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $6.83 USD +0.21

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 68.8x
Price/Book 21.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 72.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTICSMD INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at